HIDR.L vs. NOVO-B.CO

Last updated Jun 5, 2026

HIDR.L (HSBC MSCI Indonesia UCITS ETF USD) is Asia Pacific Equities fund tracking the MSCI Indonesia NR IDR, while NOVO-B.CO (Novo Nordisk A/S) is a stock. Over the past 10 years, HIDR.L returned -3.49%/yr vs 7.70%/yr for NOVO-B.CO. At a 0.14 correlation, their price movements are largely independent.

Performance

HIDR.L vs. NOVO-B.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in HSBC MSCI Indonesia UCITS ETF USD (HIDR.L) and Novo Nordisk A/S (NOVO-B.CO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

HIDR.L is traded in GBp, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, HIDR.L achieves a -39.26% return, which is significantly lower than NOVO-B.CO's -10.23% return. Over the past 10 years, HIDR.L has underperformed NOVO-B.CO with an annualized return of -3.49%, while NOVO-B.CO has yielded a comparatively higher 7.70% annualized return.

HIDR.L

• 1D: -0.63%
• 1M: -19.17%
• YTD: -39.26%
• 6M: -40.84%
• 1Y: -39.36%
• 3Y*: -23.10%
• 5Y*: -9.04%
• 10Y*: -3.49%

NOVO-B.CO

• 1D: 4.86%
• 1M: -0.24%
• YTD: -10.23%
• 6M: -4.68%
• 1Y: -35.95%
• 3Y*: -17.04%
• 5Y*: 5.23%
• 10Y*: 7.70%

*Multi-year figures are annualized to reflect compound growth (CAGR)

HIDR.L vs. NOVO-B.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HIDR.L HSBC MSCI Indonesia UCITS ETF USD	-39.26%	-8.13%	-13.17%	-0.80%	15.43%	2.40%	-11.41%	4.86%	-4.08%	12.22%
NOVO-B.CO Novo Nordisk A/S	-10.23%	-43.66%	-13.82%	47.72%	36.25%	63.66%	19.71%	25.62%	-7.39%	40.70%

Correlation

The correlation between HIDR.L and NOVO-B.CO is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.02
Correlation (3Y) Calculated over the trailing 3-year period	0.04
Correlation (5Y) Calculated over the trailing 5-year period	0.05
Correlation (10Y) Calculated over the trailing 10-year period	0.10
Correlation (All Time) Calculated using the full available price history since Apr 5, 2011	0.14

The correlation between HIDR.L and NOVO-B.CO shifts across timeframes, from 0.02 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.

Return for Risk

HIDR.L vs. NOVO-B.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIDR.L

HIDR.L Risk / Return Rank: 0
HIDR.L Sharpe Ratio Rank: 0
HIDR.L Sortino Ratio Rank: 0
HIDR.L Omega Ratio Rank: 0
HIDR.L Calmar Ratio Rank: 1
HIDR.L Martin Ratio Rank: 0

NOVO-B.CO

NOVO-B.CO Risk / Return Rank: 16
NOVO-B.CO Sharpe Ratio Rank: 12
NOVO-B.CO Sortino Ratio Rank: 15
NOVO-B.CO Omega Ratio Rank: 14
NOVO-B.CO Calmar Ratio Rank: 16
NOVO-B.CO Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIDR.L vs. NOVO-B.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HSBC MSCI Indonesia UCITS ETF USD (HIDR.L) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HIDR.L	NOVO-B.CO	Difference
Sharpe ratio: Return per unit of total volatility	-1.59	-0.67	-0.92
Sortino ratio: Return per unit of downside risk	-2.33	-0.68	-1.65
Omega ratio: Gain probability vs. loss probability	0.71	0.90	-0.20
Calmar ratio: Return relative to maximum drawdown	-0.92	-0.67	-0.24
Martin ratio: Return relative to average drawdown	-2.56	-1.02	-1.54
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HIDR.L vs. NOVO-B.CO - Sharpe Ratio Comparison

The current HIDR.L Sharpe Ratio is -1.59, which is lower than the NOVO-B.CO Sharpe Ratio of -0.67. The chart below compares the historical Sharpe Ratios of HIDR.L and NOVO-B.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	HIDR.L	NOVO-B.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.59	-0.67	-0.92
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.45	0.14	-0.59
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.16	0.23	-0.39
Sharpe Ratio (All Time) Calculated using the full available price history	-0.10	0.54	-0.64

Drawdowns

HIDR.L vs. NOVO-B.CO - Drawdown Comparison

The maximum HIDR.L drawdown since its inception was -58.31%, smaller than the maximum NOVO-B.CO drawdown of -76.13%. Use the drawdown chart below to compare losses from any high point for HIDR.L and NOVO-B.CO.

Drawdown Indicators

	HIDR.L	NOVO-B.CO	Difference
Max Drawdown Largest peak-to-trough decline	-58.31%	-76.13%	+17.82%
Max Drawdown (1Y) Largest decline over 1 year	-42.78%	-54.00%	+11.22%
Max Drawdown (3Y) Largest decline over 3 years	-54.23%	-76.13%	+21.90%
Max Drawdown (5Y) Largest decline over 5 years	-58.31%	-76.13%	+17.82%
Max Drawdown (10Y) Largest decline over 10 years	-58.31%	-76.13%	+17.82%
Current Drawdown Current decline from peak	-58.31%	-69.77%	+11.46%
Average Drawdown Average peak-to-trough decline	-18.11%	-11.65%	-6.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	15.35%	35.49%	-20.14%

Volatility

HIDR.L vs. NOVO-B.CO - Volatility Comparison

The current volatility for HSBC MSCI Indonesia UCITS ETF USD (HIDR.L) is 7.79%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 10.15%. This indicates that HIDR.L experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HIDR.L	NOVO-B.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.79%	10.15%	-2.36%
Volatility (6M) Calculated over the trailing 6-month period	20.56%	39.07%	-18.51%
Volatility (1Y) Calculated over the trailing 1-year period	24.69%	54.40%	-29.71%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.00%	38.89%	-18.89%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.57%	33.08%	-8.51%

Dividends

HIDR.L vs. NOVO-B.CO - Dividend Comparison

HIDR.L's dividend yield for the trailing twelve months is around 6.25%, more than NOVO-B.CO's 4.12% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HIDR.L HSBC MSCI Indonesia UCITS ETF USD	6.25%	4.87%	3.49%	3.49%	2.04%	1.27%	1.75%	1.61%	1.50%	1.14%	1.12%	1.59%
NOVO-B.CO Novo Nordisk A/S	4.12%	3.58%	1.59%	1.01%	1.19%	1.27%	2.02%	2.11%	2.64%	2.27%	3.69%	1.25%

Frequently Asked Questions

Can I hold both HIDR.L and NOVO-B.CO in my portfolio?

HIDR.L and NOVO-B.CO have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.